Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Mol Neurobiol. 2014 Apr 15;51(1):43–56. doi: 10.1007/s12035-014-8691-z

Table 2.

The numbers of mice used for the therapeutic study. Mice were subjected to rAAV9 or PBS injections at 10 months of age and terminated at 15 months


Number of mice subjected to AAV injection

Number of mice that survived and were examined

Number of mice that died during treatment
PBS IgVL5D3 PBS IgVL5D3 PBS IgVL5D3
TgAPPswe/PS1dE male 5 5 5 4 0 1
TgAPPswe/PS1dE female 3 2 3 1 0 1
Non-Tg male 5 7 4 7 1 0
Non-Tg female 3 4 3 3 0 1